We also demonstrate that deficiency of MKK6 in cardiomyocytes is sufficient to result in cardiac hypertrophy, attributable to both, MKK6 direct function in inducing hypertrophy via p38-mediated signaling as well as its role as a negative regulator of MKK3 activity. Here, MAP2K6 is linked to cardiac hypertrophy.